Department of Radiology
Found 29 results
Filters: Author is Zetterberg, Henrik  [Clear All Filters]
2024
Jacobs T, Jacobson SR, Fortea J, Berger JS, Vedvyas A, Marsh K, He T, Gutierrez-Jimenez E, Fillmore NR, Bubu OM et al..  2024.  The neutrophil to lymphocyte ratio associates with markers of Alzheimer's disease pathology in cognitively unimpaired elderly people.. Res Sq.
2023
Butler T, Zhou L, Ozsahin I, Wang XHugh, Garetti J, Zetterberg H, Blennow K, Jamison K, de Leon MJ, Li Y et al..  2023.  Glymphatic clearance estimated using diffusion tensor imaging along perivascular spaces is reduced after traumatic brain injury and correlates with plasma neurofilament light, a biomarker of injury severity.. Brain Commun. 5(3):fcad134.
2022
Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJelle, Aarsland D, Alcolea D, Altomare D, von Arnim C et al..  2022.  Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.. JAMA Neurol. 79(3):228-243.
2021
Pascoal TA, Benedet AL, Ashton NJ, Kang MSu, Therriault J, Chamoun M, Savard M, Lussier FZ, Tissot C, Karikari TK et al..  2021.  Microglial activation and tau propagate jointly across Braak stages.. Nat Med. 27(9):1592-1599.
Kamer AR, Pushalkar S, Gulivindala D, Butler T, Li Y, Annam KRaghava Ch, Glodzik L, Ballman KV, Corby PM, Blennow K et al..  2021.  Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly.. Alzheimers Dement (Amst). 13(1):e12172.
2019
Fossati S, Cejudo JRamos, Debure L, Pirraglia E, Sone JYeong, Li Y, Chen J, Butler T, Zetterberg H, Blennow K et al..  2019.  Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.. Alzheimers Dement (Amst). 11:483-492.
Kam K, Parekh A, Sharma RA, Andrade A, Lewin M, Castillo B, Bubu OM, Chua NJ, Miller MD, Mullins AE et al..  2019.  Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau.. Mol Neurodegener. 14(1):10.
2018
Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS et al..  2018.  Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.. JAMA Psychiatry. 75(1):84-95.
Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJelle, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L et al..  2018.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.. World J Biol Psychiatry. 19(4):244-328.
de Leon MJ, Pirraglia E, Osorio RS, Glodzik L, Saint-Louis L, Kim H-J, Fortea J, Fossati S, Laska E, Siegel C et al..  2018.  The nonlinear relationship between cerebrospinal fluid Aβ42 and tau in preclinical Alzheimer's disease.. PLoS One. 13(2):e0191240.
Sharma RA, Varga AW, Bubu OM, Pirraglia E, Kam K, Parekh A, Wohlleber M, Miller MD, Andrade A, Lewis C et al..  2018.  Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.. Am J Respir Crit Care Med. 197(7):933-943.
Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, Mintun MM, Lleó A, Molinuevo JLuis, Jagust WJ et al..  2018.  Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.. Alzheimers Dement. 14(7):913-924.
Ramos-Cejudo J, Wisniewski T, Marmar C, Zetterberg H, Blennow K, de Leon MJ, Fossati S.  2018.  Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.. EBioMedicine. 28:21-30.
2016
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al..  2016.  Clearance systems in the brain--implications for Alzheimer diseaser.. Nat Rev Neurol. 12(4):248.
Spiegel J, Pirraglia E, Osorio RS, Glodzik L, Li Y, Tsui W, Louis LASaint, Randall C, Butler T, Xu J et al..  2016.  Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.. J Alzheimers Dis. 49(1):93-100.
Osorio RS, Ducca EL, Wohlleber ME, Tanzi EB, Gumb T, Twumasi A, Tweardy S, Lewis C, Fischer E, Koushyk V et al..  2016.  Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.. Sleep. 39(6):1253-60.
Varga AW, Wohlleber ME, Giménez S, Romero S, Alonso JF, Ducca EL, Kam K, Lewis C, Tanzi EB, Tweardy S et al..  2016.  Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly.. Sleep. 39(11):2041-2048.
2015
Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S et al..  2015.  Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.. Brain. 138(Pt 9):2701-15.
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV et al..  2015.  Clearance systems in the brain-implications for Alzheimer disease.. Nat Rev Neurol. 11(8):457-70.
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, Visser PJelle, Aalten P, Aarsland D, Alcolea D et al..  2015.  Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.. JAMA. 313(19):1924-38.
2014
Glodzik L, Rusinek H, Pirraglia E, McHugh P, Tsui W, Williams S, Cummings M, Li Y, Rich K, Randall C et al..  2014.  Blood pressure decrease correlates with tau pathology and memory decline in hypertensive elderly.. Neurobiol Aging. 35(1):64-71.
Duits FH, Teunissen CE, Bouwman FH, Visser P-J, Mattsson N, Zetterberg H, Blennow K, Hansson O, Minthon L, Andreasen N et al..  2014.  The cerebrospinal fluid "Alzheimer profile": easily said, but what does it mean? Alzheimers Dement. 10(6):713-723.e2.
Osorio RS, Ayappa I, Mantua J, Gumb T, Varga A, Mooney AM, Burschtin OE, Taxin Z, During E, Spector N et al..  2014.  Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals.. Neurobiol Aging. 35(6):1318-24.
2012
Glodzik L, Mosconi L, Tsui W, de Santi S, Zinkowski R, Pirraglia E, Rich KE, McHugh P, Li Y, Williams S et al..  2012.  Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.. Neurobiol Aging. 33(7):1215-27.
2011
Glodzik L, de Santi S, Tsui WHon, Mosconi L, Zinkowski R, Pirraglia E, Wang HYu, Li Y, Rich KE, Zetterberg H et al..  2011.  Phosphorylated tau 231, memory decline and medial temporal atrophy in normal elders.. Neurobiol Aging. 32(12):2131-41.